CK-MB levels are measured through a blood test. This test, often included in cardiac enzyme panels, helps healthcare providers assess for myocardial infarction or other heart-related conditions.

Management of abnormal CK-MB levels depends on the underlying cause. In the case of a heart attack, prompt medical intervention is essential to restore blood flow to the heart and minimize damage. Treatment may include medications, such as blood thinners or clot-busting drugs, lifestyle changes, cardiac rehabilitation, or, in severe cases, procedures such as angioplasty or coronary artery bypass surgery. It's crucial to consult a healthcare provider for proper evaluation and management.

Abnormal CK-MB levels, particularly elevated levels, may indicate heart muscle damage, such as that occurring during a heart attack. However, elevated CK-MB levels can also be seen in other conditions affecting heart muscle, such as myocarditis or cardiac surgery.

CK-MB is an important biomarker for diagnosing acute myocardial infarction (heart attack). Elevated levels of CK-MB in the blood indicate damage to heart muscle cells, providing valuable diagnostic information to healthcare providers.